Lomefloxacin
Top View
- Quinolone Antibiotics
- Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
- United States Patent (19) 11 Patent Number: 5,872,104 Vermeulen Et Al
- Development of New Novel Bacterial Topoisomerase Inhibitors As Promising Antibiotics with a 5-Amino-1,3-Dioxane Linker Moiety DI
- Mycobacterium Tuberculosis DNA Gyrase As a Target for Drug Discovery
- Inhibitors of Nucleic Acid Synthesis the Antibacterial Drugs That Inhibit
- Determination of Quinolone Antibiotic Residues in Chicken by Ultra-High
- Antimicrobial Therapy for Chronic Bacterial Prostatitis (Review)
- Physicochemical Properties of Lomefloxacin, Levofloxacin, and Moxifloxacin Relevant to the Biopharmaceutics Classification Syste
- Micelle Enhanced Spectrofluorimetric Method for the Determination of Ofloxacin and Lomefloxacin in Human Urine and Serum
- E.Johnson Supplementary
- Quinolones and Fluoroquinolones Art. 31
- Critically Important Antimicrobials for Human Medicine, 6Th Revision
- Guidelines on Urological Infections
- Antimicrobial Medicines Consumption in Eastern Europe and Central Asia – an Updated Cross-National Study and Assessment of Quantitative Metrics for Policy Action
- A Risk-Benefit Assessment of Levofloxacin in Respiratory, Skin and Skin Structure, and Urinary Tract Infections
- Concept ID Name Class 1319998 Acebutolol Adrenergics 1154343
- Maxaquin Lomefloxacin Hydrochloride Tablets to Reduce the Development